| | |
| Clinical data | |
|---|---|
| Other names | ECYPLA |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C21H25N3O |
| Molar mass | 335.451 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ECPLA (N-ethyl-N-cyclopropyllysergamide) is an analog of lysergic acid diethylamide (LSD) and an isomer of the LSZ developed by Synex Synthetics [2] . In studies in mice, it was found to have approximately 40% the potency of LSD. [3] [4]